Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chimeric Therapeutics Limited has announced an application for the quotation of over 10 million new fully paid ordinary shares, marked under the ASX security code CHM, which are to be issued on August 2, 2024. This move signals a new phase for the company, potentially stirring the interest of investors looking for fresh opportunities in the biotech sector.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.